Skip to main content
Top
Published in: Clinical and Translational Oncology 1/2019

Open Access 01-01-2019 | Clinical Guides in Oncology

SEOM clinical guidelines to primary prevention of cancer (2018)

Authors: J. Bayo, R. Molina, J. Pérez, E. Pérez-Ruíz, J. Aparicio, C. Beato, J. P. Berros, M. Bolaños, B. Graña, A. Santaballa

Published in: Clinical and Translational Oncology | Issue 1/2019

Login to get access

Abstract

Cancer is the leading social and healthcare problem of the twenty-first century. The aim of primary prevention is to decrease the incidence of cancer by avoiding the known causes and risk factors. Nevertheless, it has been estimated that cancer diagnoses could be halved through primary prevention measures. A comprehensive review of the scientific evidence regarding the main carcinogens and risk factors and primary prevention recommendations have been put forth based on this evidence. The GRADE scale has been used to classify the grade of evidence. We present the scientific evidence and recommendations for primary prevention of the major modifiable risk factors: smoking, alcohol, diet, obesity, physical activity, occupational and environmental factors, ultraviolet radiation, infections, and socioeconomic factors. Primary prevention is a simple, effective means to lower the incidence of cancer. Preventive measures must be circulated in the fight against cancer.
Literature
2.
go back to reference Bayo J et al. (2017) Manual SEOM de prevención y diagnóstico del cáncer. Madrid, 33-42. Bayo J et al. (2017) Manual SEOM de prevención y diagnóstico del cáncer. Madrid, 33-42.
3.
go back to reference International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. IARC, Lyon, pp 1179. International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. IARC, Lyon, pp 1179.
4.
go back to reference International Agency for Research on Cancer (2010) Alcohol Consumption and Ethyl Carbamate. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 96. IARC, Lyon. International Agency for Research on Cancer (2010) Alcohol Consumption and Ethyl Carbamate. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 96. IARC, Lyon.
5.
go back to reference Lougan J, Bourassa MW. The rationale for a role for diet and nutrition in the prevention and treatment of cancer. Eur J Cancer Prev. 2018;27(4):406–10.CrossRef Lougan J, Bourassa MW. The rationale for a role for diet and nutrition in the prevention and treatment of cancer. Eur J Cancer Prev. 2018;27(4):406–10.CrossRef
6.
go back to reference Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, et al. Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol Hematol. 2018;123:57–73.CrossRefPubMed Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, et al. Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol Hematol. 2018;123:57–73.CrossRefPubMed
7.
go back to reference Grosso J, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, et al. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietry patterns, lifestyle factors, and cancer risks. Nutr Rev. 2017;75(6):405–19.CrossRefPubMed Grosso J, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, et al. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietry patterns, lifestyle factors, and cancer risks. Nutr Rev. 2017;75(6):405–19.CrossRefPubMed
8.
go back to reference Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to diet and physical activity cancer prevention guidelines and cancer outcomes: a systematic review. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1018–28.CrossRefPubMedPubMedCentral Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to diet and physical activity cancer prevention guidelines and cancer outcomes: a systematic review. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1018–28.CrossRefPubMedPubMedCentral
9.
go back to reference Bouvard V, Loomis D, Guyton K, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–600.CrossRefPubMed Bouvard V, Loomis D, Guyton K, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–600.CrossRefPubMed
10.
go back to reference International Agency for Research on Cancer. IARC hand-books of cancer prevention: weight control prevention: weight control and physical activity, vol. 6. Lyon: IARC Press; 2002. International Agency for Research on Cancer. IARC hand-books of cancer prevention: weight control prevention: weight control and physical activity, vol. 6. Lyon: IARC Press; 2002.
12.
go back to reference Organization Mundial of the Salud, Global recommendations on physical activity for health. 2010: Geneva. ISBN: 9789241599979. Organization Mundial of the Salud, Global recommendations on physical activity for health. 2010: Geneva. ISBN: 9789241599979.
13.
go back to reference Stewart BW, Kleihues P. World Cancer Report 2003. Lyon: IARC Press. ISBN-13 9789283204114. Stewart BW, Kleihues P. World Cancer Report 2003. Lyon: IARC Press. ISBN-13 9789283204114.
14.
go back to reference World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington: AICR; 2007. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington: AICR; 2007.
15.
go back to reference IARC. A review of human carcinogens. D.Radiation. IARC monographs on the evaluation of carcinogenic risk to humans. IARC Monogr. 2012;100:35–111. IARC. A review of human carcinogens. D.Radiation. IARC monographs on the evaluation of carcinogenic risk to humans. IARC Monogr. 2012;100:35–111.
16.
go back to reference Greinert R, De Vries E, Erdmann F, Espina C, Auvinen A, Kesminiene A, et al. European Code against cancer 4th edition: ultraviolet radiation and cancer. Cancer Epidemiol. 2015;1(Suppl 1):75–83.CrossRef Greinert R, De Vries E, Erdmann F, Espina C, Auvinen A, Kesminiene A, et al. European Code against cancer 4th edition: ultraviolet radiation and cancer. Cancer Epidemiol. 2015;1(Suppl 1):75–83.CrossRef
17.
go back to reference US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, et al. Behavioral counseling to prevent skin cancer US preventive services task force recommendation statement. Jama. 2018;319(11):1134–42.CrossRef US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, et al. Behavioral counseling to prevent skin cancer US preventive services task force recommendation statement. Jama. 2018;319(11):1134–42.CrossRef
18.
go back to reference Mueller N. Infectious agents. In: Colditz GA, Hunter DJ, editors. Cancer prevention: the causes and prevention of cancer—volume 1. Netherlands: Springer; 2000. p. 63–73. Mueller N. Infectious agents. In: Colditz GA, Hunter DJ, editors. Cancer prevention: the causes and prevention of cancer—volume 1. Netherlands: Springer; 2000. p. 63–73.
19.
go back to reference International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses, vol. 6. Lyon: IARC; 1995. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses, vol. 6. Lyon: IARC; 1995.
20.
go back to reference International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans: hepatitis viruses, vol. 59. Lyon: IARC; 1994. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans: hepatitis viruses, vol. 59. Lyon: IARC; 1994.
21.
go back to reference Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control. 2005;16:5–14.CrossRefPubMed Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control. 2005;16:5–14.CrossRefPubMed
22.
go back to reference Merletti F, Galassi C, Spadea T. The socioeconomic determinants of cancer. Environ Health. 2011;10(suppl 1):1–7.CrossRef Merletti F, Galassi C, Spadea T. The socioeconomic determinants of cancer. Environ Health. 2011;10(suppl 1):1–7.CrossRef
23.
go back to reference Aguado MJ, Rohlfs I, Sarmiento V, Márquez S. Investigation in Spain sobre desigualdades in the incidence, mortality, prevention and atention del cancer. Ministerio of Sanity and Política Social 2010. Edita Agencia de Evaluacion de Tecnologias Sanitarias en Andalucia. ISBN: 9788496990357. Aguado MJ, Rohlfs I, Sarmiento V, Márquez S. Investigation in Spain sobre desigualdades in the incidence, mortality, prevention and atention del cancer. Ministerio of Sanity and Política Social 2010. Edita Agencia de Evaluacion de Tecnologias Sanitarias en Andalucia. ISBN: 9788496990357.
24.
go back to reference Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al. European union working group on socioeconomic inequalities in health socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;5:2468–81 (Erratum in: N Engl J Med. 2008; 358(23): 2468-81).CrossRef Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al. European union working group on socioeconomic inequalities in health socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;5:2468–81 (Erratum in: N Engl J Med. 2008; 358(23): 2468-81).CrossRef
Metadata
Title
SEOM clinical guidelines to primary prevention of cancer (2018)
Authors
J. Bayo
R. Molina
J. Pérez
E. Pérez-Ruíz
J. Aparicio
C. Beato
J. P. Berros
M. Bolaños
B. Graña
A. Santaballa
Publication date
01-01-2019
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 1/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-02016-4

Other articles of this Issue 1/2019

Clinical and Translational Oncology 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine